KRYSTAL BIOTECH INC. - COMMON STOCK
164.10
17-5月-24 15:59:59
15 分の遅延
株式
+0.32
+0.20%
本日の幅
160.95 - 164.38
ISIN
N/A
ソース
NASDAQ
-
Krystal Biotech to Present at 5th Annual Evercore ISI HealthCONx Conference
23 11 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Krystal Biotech Announces Third Quarter 2022 Financial Results and Operational Highlights
07 11 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Krystal Biotech to Present at Chardan’s 6th Annual Genetic Medicines Conference
29 9 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
21 9 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Krystal Biotech to Present at H.C. Wainwright 24th Annual Global Investment Conference
08 9 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
FDA Accepts Krystal Biotech’s Biologics License Application for Dystrophic Epidermolysis Bullosa
18 8 2022 17:00:00 提供 Nasdaq GlobeNewswire
-
08 8 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Krystal Biotech Announces FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial
01 8 2022 18:39:37 提供 Nasdaq GlobeNewswire
-
Krystal Biotech to Present at William Blair Biotech Focus Conference 2022
06 7 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
22 6 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
22 6 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Krystal Biotech to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
07 6 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
19 5 2022 19:30:00 提供 Nasdaq GlobeNewswire
-
09 5 2022 16:15:00 提供 Nasdaq GlobeNewswire
-
Krystal Biotech to Participate in Bank of America Merrill Lynch Global Healthcare Conference
03 5 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Krystal Biotech Announces Home Dosing in B-VEC Open Label Extension Study
11 4 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
28 3 2022 11:00:00 提供 Nasdaq GlobeNewswire
-
New GEM-3 Phase 3 Results for B-VEC Presented at 2022 American Academy of Dermatology Annual Meeting
26 3 2022 12:00:00 提供 Nasdaq GlobeNewswire
-
Krystal Biotech to Participate in H.C. Wainwright and Guggenheim Investor Conferences
24 3 2022 07:00:01 提供 Nasdaq GlobeNewswire